MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 377 filers reported holding MEDIVATION INC in Q1 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $215,865,000 | +32.5% | 3,579,877 | +1.0% | 0.18% | +29.8% |
| Q1 2016 | $162,950,000 | +11.5% | 3,543,891 | +17.2% | 0.14% | +12.8% |
| Q4 2015 | $146,195,000 | -52.0% | 3,024,324 | -57.8% | 0.12% | -8.8% |
| Q3 2015 | $304,746,000 | +47.4% | 7,170,514 | +296.0% | 0.14% | -19.4% |
| Q2 2015 | $206,807,000 | -5.4% | 1,810,915 | +6.9% | 0.17% | -5.6% |
| Q1 2015 | $218,626,000 | -1.6% | 1,693,858 | -24.1% | 0.18% | -5.3% |
| Q4 2014 | $222,158,000 | -39.6% | 2,230,276 | -40.1% | 0.19% | -43.5% |
| Q3 2014 | $368,081,000 | +6.2% | 3,722,893 | -17.2% | 0.34% | +5.7% |
| Q2 2014 | $346,616,000 | +21.3% | 4,497,073 | +1.3% | 0.32% | +19.5% |
| Q1 2014 | $285,734,000 | -13.5% | 4,438,957 | -14.2% | 0.27% | -14.5% |
| Q4 2013 | $330,296,000 | +6.0% | 5,175,283 | -0.4% | 0.31% | +0.6% |
| Q3 2013 | $311,490,000 | +17.7% | 5,196,508 | -3.4% | 0.31% | +12.0% |
| Q2 2013 | $264,658,000 | – | 5,379,111 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |